Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system of the ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system of ...

Abe Hiroshi, a professor at Nagoya University, said, "Currently used mRNA drugs are unstable and require repeated injections, but the technology developed this time can address these issues.

Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Scientists have developed a lipid nanoparticle system that enables mRNA to cross the blood-brain barrier, a long-standing challenge in n.

The study suggests that mRNA-based therapies could have a role ... Seven of the patients received the drug during CABG, while four had a placebo injection. The data is clearly very preliminary ...

The “Make America Healthy Again” commission is reviewing certain vaccines as some states push to restrict the use of COVID-19 ...

We share a common vision with AstraZeneca for how mRNA therapeutics will enable many new innovative drugs for targets which are totally undruggable today. We look forward to this unique ...

Left to right - Dr. Riccardo Rampado & Prof. Dan Peer. Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid nanoparticles ...